Detalhe da pesquisa
1.
The CXCL12/CXCR4 Signaling Pathway: A New Susceptibility Factor in Human Papillomavirus Pathogenesis.
PLoS Pathog
; 12(12): e1006039, 2016 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-27918748
2.
CXCR4-Specific Nanobodies as Potential Therapeutics for WHIM syndrome.
J Pharmacol Exp Ther
; 363(1): 35-44, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28768817
3.
Integration of New Information with Active Memory Accounts for Retrograde Amnesia: A Challenge to the Consolidation/Reconsolidation Hypothesis?
J Neurosci
; 35(33): 11623-33, 2015 Aug 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-26290239
4.
Patient-derived tumoroids and proteomic signatures: tools for early drug discovery.
Front Immunol
; 15: 1379613, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38698850
5.
Differential activity and selectivity of N-terminal modified CXCL12 chemokines at the CXCR4 and ACKR3 receptors.
J Leukoc Biol
; 107(6): 1123-1135, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32374043
6.
Interaction of chemokine receptor CXCR4 in monomeric and dimeric state with its endogenous ligand CXCL12: coarse-grained simulations identify differences.
J Biomol Struct Dyn
; 35(2): 399-412, 2017 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26813575
7.
Natural amines inhibit activation of human plasmacytoid dendritic cells through CXCR4 engagement.
Nat Commun
; 8: 14253, 2017 02 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28181493